Elevated HIF-1α expression of acute myelogenous leukemia stem cells in the endosteal hypoxic zone may be a cause of minimal residual disease in bone marrow after chemotherapy
Authors:
- T. MatsunagaTMT. Matsunaga
- O. ImatakiOIO. Imataki
- E. ToriiETE. Torii
- T. KamedaTKT. Kameda
- K. ShideKSK. Shide
- H. ShimodaHSH. Shimoda
- A. KamiuntenAKA. Kamiunten
- M. SekineMSM. Sekine
- Y. TaniguchiYTY. Taniguchi
- S. YamamotoSYS. Yamamoto
- T. HidakaTHT. Hidaka
- K. KatayoseKKK. Katayose
- 23 March 2012
- journal article
- other
- Published by Elsevier in Leukemia Research
- Vol. 36 (6) , e122-e124
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AMLNature Biotechnology, 2010
- Rendering the Leukemia Cell Susceptible to AttackNew England Journal of Medicine, 2009
- Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal regionNature Biotechnology, 2007
- Targeting of CD44 eradicates human acute myeloid leukemic stem cellsNature Medicine, 2006
- Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatment with chemotherapy and antilineage-specific antibodiesLeukemia, 2003
- Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemiaNature Medicine, 2003
- Stromal cells regulate survival of B-lineage leukemic cells during chemotherapyBlood, 2000
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivoNature Medicine, 1999
- The frequency of long‐term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow‐up time of 6 yearsBritish Journal of Haematology, 1989